Shaun Bagai - 25 Aug 2021 Form 3 Insider Report for RenovoRx, Inc. (RNXT)

Role
Chief Executive Officer, Director
Signature
/s/ Shaun R. Bagai
Issuer symbol
RNXT
Transactions as of
25 Aug 2021
Net transactions value
$0
Form type
3
Filing time
25 Aug 2021, 17:28:58 UTC
Next filing
04 Oct 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding RNXT Stock Option (right to buy) 25 Aug 2021 Common Stock 120,000 $0.6500 Direct F1
holding RNXT Stock Option (right to buy) 25 Aug 2021 Common Stock 60,000 $0.5000 Direct F2
holding RNXT Stock Option (right to buy) 25 Aug 2021 Common Stock 246,057 $0.1500 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/48th of the shares subject to the option began vesting monthly on April 19, 2018, and the remaining unvested shares will continue to vest according to the same schedule until fully vested on April 19, 2022.
F2 The shares subject to the option are fully vested.
F3 The shares subject to the option are fully vested.